NUMELVI
Active Ingredient: ATINVICITINIB
Product Overview
About NUMELVI
NUMELVI is a prescription medication containing the active ingredient ATINVICITINIB. It is used to treat certain types of cancer, specifically non-small cell lung cancer (NSCLC) with a specific genetic mutation.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with a specific EGFR mutation
- Targeted therapy to inhibit the growth and spread of cancer cells
- May be used in combination with other medications to enhance treatment efficacy
Active Ingredient & Action
ATINVICITINIB is a tyrosine kinase inhibitor that works by blocking the activity of a specific enzyme involved in the growth and spread of cancer cells. By inhibiting this enzyme, ATINVICITINIB helps to slow down or stop the growth of cancer cells, thereby reducing the size of tumors and slowing disease progression.
Important Notes
NUMELVI is a prescription medication and should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and treatment schedule to ensure optimal efficacy and minimize potential side effects. Patients should be monitored regularly for signs of adverse reactions and adjust treatment as needed.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.